| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
49 companies · Health Care
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2025 | CDNA Caredx, Inc. | Maag Peter | Director | Sell | 10,000 | $19.24 | $192,420.00 | -3.0% | |
| Jun 17, 2025 | GH Guardant Health, Inc. | Clark Ian T | Director | Sell | 6,672 | $48.38 | $322,818.72 | -40.4% | |
| Jun 16, 2025 | NTRA Natera, Inc. | Sheena Jonathan | - | Sell | 3,000 | $164.55 | $493,649.29 | -1.0% | |
| Jun 16, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 3,729 | $64.77 | $241,538.52 | -29.8% | |
| Jun 16, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 10,501 | $64.77 | $680,181.27 | -41.8% | |
| Jun 16, 2025 | TWST Twist Bioscience Corp | Cho Dennis | See Remarks | Sell | 94 | $33.48 | $3,146.65 | - | |
| Jun 16, 2025 | GH Guardant Health, Inc. | Potter Myrtle S | Director | Sell | 2,626 | $49.70 | $130,512.20 | -12.6% | |
| Jun 13, 2025 | VCYT Veracyte, Inc. | Eastham Karin | Director | Sell | 4,590 | $26.66 | $122,387.76 | -24.8% | |
| Jun 13, 2025 | VCYT Veracyte, Inc. | Bhanji Muna | Director | Sell | 4,589 | $26.67 | $122,366.60 | -13.3% | |
| Jun 13, 2025 | GH Guardant Health, Inc. | Joyce Meghan V. | Director | Sell | 3,337 | $47.22 | $157,573.14 | -23.0% | |
| Jun 13, 2025 | EXAS Exact Sciences Corp | Zanotti Katherine S | Director | Sell | 3,207 | $53.20 | $170,612.40 | -4.2% | |
| Jun 13, 2025 | NTRA Natera, Inc. | Rabinowitz Matthew | Executive Chairman | Sell | 5,000 | $165.85 | $829,250.00 | -14.3% | |
| Jun 12, 2025 | GRAL Grail, Inc. | Ofman Joshua J. | President | Sell | 9,692 | $42.30 | $410,019.09 | -1.9% | |
| Jun 11, 2025 | CDNA Caredx, Inc. | Hagstrom William A | Director | Sell | 19,391 | $19.90 | $385,917.74 | -26.4% | |
| Jun 10, 2025 | NTRA Natera, Inc. | Marcus Gail Boxer | Director | Sell | 4,000 | $164.44 | $657,760.90 | -25.0% | |
| Jun 9, 2025 | WGS Genedx Holdings Corp. | Stueland Katherine | Chief Executive Officer | Sell | 3,639 | $72.55 | $264,009.45 | -36.4% | |
| Jun 9, 2025 | WGS Genedx Holdings Corp. | Feeley Kevin | Chief Financial Officer | Sell | 1,266 | $72.55 | $91,848.30 | -19.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.